Cannabis during pregnancy: risks, breastfeeding and THC
Cannabis during pregnancy is not a gray area — it is an absolute contraindication. This applies to both THC and CBD, to occasional and regular use, to the first trimester as well as to breastfeeding. What developmental biology explains behind this and why “natural” does not mean “safe”.
Overview
hide
Why Cannabis during Pregnancy is Absolutely Contraindicated
The clarity of the medical recommendation comes from several strands of evidence:
- No safe dose known: There is no scientifically established threshold below which cannabis use during pregnancy is considered safe. Neither for THC nor for CBD is there a dosage limit that has been proven safe
- THC crosses the placenta and blood-brain barrier: THC is lipophilic — it efficiently crosses the placental barrier and reaches fetal tissue. In the fetus, the blood-brain barrier is still incompletely developed — THC reaches the developing brain in significant amounts
- Critical developmental windows: The fetal brain undergoes critical phases of neurogenesis, migration, differentiation, and synaptic circuit formation between the 5th and 25th weeks of gestation — all ECS-regulated processes. Exogenous cannabinoids disrupt this precisely timing-dependent development
- ACOG Position: The American College of Obstetricians and Gynecologists (ACOG) and the German Society of Gynecology explicitly recommend abstinence — no cannabis during pregnancy or breastfeeding, without exception
THC and fetal brain development: The mechanism
The endocannabinoid system is not only active in the adult brain — it regulates crucial developmental steps:
- ECS as a developmental regulator: 2-AG and anandamide are endogenous signaling molecules that regulate fetal neuron migration (movement of neurons to their target position), axonal sprouting, and synaptic densification. CB1 receptors are already detectable in the human fetal cortex from the 5th week of gestation
- THC as a disrupting factor: Exogenous THC binds to CB1 more strongly and for a longer time than anandamide (anandamide is rapidly broken down by FAAH, but THC is not). This prolonged CB1 activation shifts developmental time windows — neurons migrate too early or too late, axons sprout in the wrong direction
- Dopaminergic system: Prenatal THC exposure affects the development of the mesolimbic dopamine system — increased vulnerability to ADHD, impulse control problems, and increased risk of addiction in children
- El Marroun et al. 2019 (JAMA Psychiatry): Prospective cohort study (Generation R, N=2,972). Prenatal cannabis exposure associated with increased internalizing scores (anxiety, withdrawal) and externalizing problems in children up to the age of 9 years. Neuroimaging: structural changes in the prefrontal cortex
- Fried et al. (Ottawa Prenatal Prospective Study): Long-term cohort study over 20+ years: prenatal cannabis exposure associated with reduced executive function, attention, and working memory in adolescence — even after adjustment for tobacco, alcohol, and socioeconomic status
Pregnancy complications: What the data show
Fetal brain development is not the only concern:
- Small for Gestational Age (SGA): Conner et al. 2016 (Obstetrics & Gynecology): Cannabis use during pregnancy significantly increased the risk of low birth weight (SGA, below the 10th percentile) — after adjustment for smoking and other factors. Mechanism: THC-induced fetal-placental vasoconstriction reduces nutrient supply
- Premature birth: Several cohort studies show increased preterm birth rates among cannabis users. Odds ratio 1.3–1.5 depending on the study and dosage of consumption
- Stillbirth: Brown et al. 2019 (BMJ) showed in a large US cohort an increased risk of stillbirth with cannabis use during pregnancy (OR 2.34) — especially with daily use
- Nausea during pregnancy — the most common reason for self-medication: Many women with Hyperemesis Gravidarum turn to cannabis. ACOG explicitly warns against this — the teratogenic risks far outweigh the benefits. Evidence-based alternatives: Ondansetron, Dimenhydrinate, Pyridoxine, Metoclopramide
Related
Cannabis during breastfeeding: THC in breast milk
The contraindication does not end with birth:
- THC accumulates in breast milk: THC is highly lipophilic and actively accumulates in the fatty breast milk — the concentration in breast milk is 8 times higher than in maternal blood plasma
- Baker et al. 2018 (Obstetrics & Gynecology): THC was detectable in breast milk up to 6 days after last use — longer in regular users. A single use is sufficient for multi-day exposure of the breastfed child
- Delayed fetal excretion: The newborn brain metabolizes THC more slowly than the adult brain (underdeveloped liver function, incomplete blood-brain barrier). Same dose → stronger and longer exposure
- Developmental consequences for the breastfed child: Thielin et al. and other studies show motor developmental delays in children exposed to THC through breast milk — especially during the first year of life
- Pumping and dumping is not sufficient: Due to enrichment in fat deposits, the mother excretes THC over several hours. “Pump and dump” has no reliable evidence as a safety strategy
CBD during pregnancy: Not safe
- No safety data: There are no human safety studies on CBD during pregnancy. The FDA explicitly warns against CBD supplements during pregnancy
- Animal models — alarming signals: Animal models show that CBD can affect placental function and penetrate fetal tissue. The extrapolation to humans is unclear — but there is no signal for safety
- CBD products of unregulated origin: Many CBD products contain THC traces or other uncontrolled cannabinoids. The contamination risk is not assessable with uncontrolled product quality
- Conclusion: No CBD during pregnancy or breastfeeding — not even for established indications such as anxiety or sleep. Prefer evidence-based alternatives with safety data during pregnancy
Who the warning is especially important for
- Women with chronic diseases: Those who use cannabis medically for pain therapy, endometriosis, or anxiety — must stop immediately upon pregnancy or planning and inform the prescribing doctor. Initiate alternative therapies
- Unnoticed early pregnancy: Many pregnancies are only noticed between the 5th and 8th week of gestation — one of the most critical developmental phases. Those who could become pregnant: Cautionarily stop consumption
- Couples trying to conceive: THC affects sperm quality (motility, DNA integrity) in men and the hormone status and cycle regularity in women. Abstinence is also sensible before conception
- Open conversation with the gynecologist: Many pregnant women do not mention cannabis use — out of fear of consequences. Honesty is important for appropriate support. No stigmatization, but clear medical information
Cannabis during menstruation and the cycle — what is relevant before pregnancy: Cannabis for PMS and Menstruation. The endocannabinoid system and its role in development: Cannabis and the Immune System. CBD vs. THC — differences in safety profile and effects: CBD vs. THC.
Frequently asked questions about cannabis during pregnancy
Related
Cannabis for restless legs: CBD, dopamine & studies
Cannabis & bones: CB2, osteoporosis & bone healing
Cannabis & testosterone: effect on male fertility
Cannabis quality: laboratory tests, pesticides & contamination
Home cannabis cultivation: rules according to CanG
Cannabis microdosing: low doses of THC & CBD
More
CBN (cannabinol): Sleep sedative & effect explained
Cannabis for ADHD: THC, CBD & concentration - Studies
CBG (cannabigerol): effect, studies & application
Cannabis decarboxylation: activating THCA to THC
Cannabis in sport: CBD, regeneration & doping test
Cannabis & heart: cardiovascular risks explained
THC tolerance: how it develops and how to reduce it
Cannabis & immune system: CB2 receptors & inflammation
Cannabis in palliative care: pain & quality of life
Delta-8-THC & Delta-10-THC: Effect, difference & law
